BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $20,993,000 | +689.5% | 20,256,000 | +710.2% | 0.89% | +621.0% |
| Q2 2018 | $2,659,000 | +3.4% | 2,500,000 | 0.0% | 0.12% | -3.1% |
| Q1 2018 | $2,571,000 | -53.8% | 2,500,000 | -50.0% | 0.13% | -52.6% |
| Q2 2017 | $5,559,000 | +19.5% | 5,000,000 | +19.2% | 0.27% | -13.2% |
| Q2 2016 | $4,653,000 | +11.5% | 4,196,000 | +16.2% | 0.31% | +21.0% |
| Q1 2016 | $4,174,000 | -86.0% | 3,610,000 | -84.4% | 0.26% | -85.4% |
| Q4 2015 | $29,745,000 | +12.4% | 23,110,000 | +14.0% | 1.77% | +13.4% |
| Q3 2015 | $26,472,000 | -6.8% | 20,271,000 | +10.0% | 1.56% | +17.7% |
| Q2 2015 | $28,392,000 | +381.8% | 18,424,000 | +360.6% | 1.32% | +342.8% |
| Q1 2015 | $5,893,000 | – | 4,000,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ferox Capital Management LP | 6,000,000 | $6,271,000 | 4.60% |
| Weiss Asset Management LP | 27,058,000 | $28,040,000 | 2.16% |
| Birch Grove Capital LP | 4,643,000 | $4,802,000 | 1.91% |
| CSS LLC/IL | 20,256,000 | $20,993,000 | 0.89% |
| PIPER SANDLER & CO. | 1,000,000 | $1,036,000 | 0.86% |
| AQR Arbitrage LLC | 24,825,000 | $25,686,000 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 17,000,000 | $17,589,000 | 0.20% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,000,000 | $5,182,000,000 | 0.12% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,107,000 | $4,256,000 | 0.12% |
| Verition Fund Management LLC | 3,106,000 | $3,214,000 | 0.12% |